Burning Rock Biotech Limited
BNR
$23.15
$0.401.76%
NASDAQ
| 09/30/2025 | 03/31/2025 | 12/31/2024 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 18.39M | 18.30M | 17.52M | 17.52M | 17.97M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 18.39M | 18.30M | 17.52M | 17.52M | 17.97M |
| Cost of Revenue | 4.58M | 4.91M | 5.09M | 5.09M | 5.14M |
| Gross Profit | 13.81M | 13.39M | 12.43M | 12.43M | 12.83M |
| SG&A Expenses | 10.27M | 9.93M | 11.68M | 11.68M | 11.35M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 20.64M | 20.38M | 24.02M | 24.02M | 23.36M |
| Operating Income | -2.25M | -2.09M | -6.51M | -6.51M | -5.39M |
| Income Before Tax | -2.31M | -1.83M | -10.56M | -10.56M | -4.97M |
| Income Tax Expenses | 29.60K | 30.80K | 738.70K | 738.70K | 28.10K |
| Earnings from Continuing Operations | -2.34M | -1.86M | -11.30M | -11.30M | -4.99M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.34M | -1.86M | -11.30M | -11.30M | -4.99M |
| EBIT | -2.25M | -2.09M | -6.51M | -6.51M | -5.39M |
| EBITDA | -458.90K | -320.60K | -4.72M | -4.72M | -799.90K |
| EPS Basic | -2.17 | -1.73 | -10.93 | -10.93 | -4.84 |
| Normalized Basic EPS | -0.13 | -0.11 | -0.34 | -0.34 | -0.30 |
| EPS Diluted | -2.17 | -1.73 | -10.93 | -10.93 | -4.84 |
| Normalized Diluted EPS | -0.13 | -0.11 | -0.34 | -0.34 | -0.30 |
| Average Basic Shares Outstanding | 10.77M | 10.76M | 10.34M | 10.34M | 10.32M |
| Average Diluted Shares Outstanding | 1.08M | 1.08M | 1.03M | 1.03M | 1.03M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |